WILLIAM MOORE: Open Payments
NPI 1407089907 · GAUTIER, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 39 payments from 10 companies in 2025. Trend: 2023 $1,168 · 2024 $996 · 2025 $983
Food & beverage: $983
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 16 | $439 |
| Novo Nordisk Inc | 7 | $222 |
| Abbott Laboratories | 3 | $72 |
| Xeris Pharmaceuticals, Inc. | 3 | $69 |
| Amgen Inc. | 3 | $50 |
| Corcept Therapeutics | 2 | $41 |
| Insulet Corporation | 2 | $34 |
| Exact Sciences Corporation | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
Products named: MINIMED 780G, Ozempic, INCEPTIV, FREESTYLE LIBRE 3, GVOKE HYPOPEN, EVENITY, Korlym, Omnipod.
Industry payments across MS — which companies pay providers there.
